Literature DB >> 30320744

In Vivo Microdialysis Method to Collect Large Extracellular Proteins from Brain Interstitial Fluid with High-molecular Weight Cut-off Probes.

Kaoru Yamada1.   

Abstract

In vivo microdialysis is a powerful technique to collect ISF from awake, freely-behaving animals based on a dialysis principle. While microdialysis is an established method that measures relatively small molecules including amino acids or neurotransmitters, it has been recently used to also assess dynamics of larger molecules in ISF using probes with high molecular weight cut off membranes. Upon using such probes, microdialysis has to be run in a push-pull mode to avoid pressure accumulated inside of the probes. This article provides step-by-step protocols including stereotaxic surgery and how to set up microdialysis lines to collect proteins from ISF. During microdialysis, drugs can be administered either systemically or by direct infusion into ISF. Reverse microdialysis is a technique to directly infuse compounds into ISF. Inclusion of drugs in the microdialysis perfusion buffer allows them to diffuse into ISF through the probes while simultaneously collecting ISF. By measuring tau protein as an example, the author shows how its levels are altered upon stimulating neuronal activity by reverse microdialysis of picrotoxin. Advantages and limitations of microdialysis are described along with the extended application by combining other in vivo methods.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30320744      PMCID: PMC6235288          DOI: 10.3791/57869

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  17 in total

1.  Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.

Authors:  Shuko Takeda; Caitlin Commins; Sarah L DeVos; Chloe K Nobuhara; Susanne Wegmann; Allyson D Roe; Isabel Costantino; Zhanyun Fan; Samantha B Nicholls; Alexis E Sherman; Ana T Trisini Lipsanopoulos; Clemens R Scherzer; George A Carlson; Rose Pitstick; Elaine R Peskind; Murray A Raskind; Ge Li; Thomas J Montine; Matthew P Frosch; Bradley T Hyman
Journal:  Ann Neurol       Date:  2016-08-03       Impact factor: 10.422

2.  Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

Authors:  John R Cirrito; Kelvin A Yamada; Mary Beth Finn; Robert S Sloviter; Kelly R Bales; Patrick C May; Darryle D Schoepp; Steven M Paul; Steven Mennerick; David M Holtzman
Journal:  Neuron       Date:  2005-12-22       Impact factor: 17.173

3.  Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.

Authors:  Joseph M Castellano; Jungsu Kim; Floy R Stewart; Hong Jiang; Ronald B DeMattos; Bruce W Patterson; Anne M Fagan; John C Morris; Kwasi G Mawuenyega; Carlos Cruchaga; Alison M Goate; Kelly R Bales; Steven M Paul; Randall J Bateman; David M Holtzman
Journal:  Sci Transl Med       Date:  2011-06-29       Impact factor: 17.956

4.  In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice.

Authors:  Kaoru Yamada; John R Cirrito; Floy R Stewart; Hong Jiang; Mary Beth Finn; Brandon B Holmes; Lester I Binder; Eva-Maria Mandelkow; Marc I Diamond; Virginia M-Y Lee; David M Holtzman
Journal:  J Neurosci       Date:  2011-09-14       Impact factor: 6.167

5.  In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.

Authors:  John R Cirrito; Patrick C May; Mark A O'Dell; Jennie W Taylor; Maia Parsadanian; Jeffrey W Cramer; James E Audia; Jeffrey S Nissen; Kelly R Bales; Steven M Paul; Ronald B DeMattos; David M Holtzman
Journal:  J Neurosci       Date:  2003-10-01       Impact factor: 6.167

6.  Physiological release of endogenous tau is stimulated by neuronal activity.

Authors:  Amy M Pooler; Emma C Phillips; Dawn H W Lau; Wendy Noble; Diane P Hanger
Journal:  EMBO Rep       Date:  2013-02-15       Impact factor: 8.807

7.  Neuronal activity regulates the regional vulnerability to amyloid-β deposition.

Authors:  Adam W Bero; Ping Yan; Jee Hoon Roh; John R Cirrito; Floy R Stewart; Marcus E Raichle; Jin-Moo Lee; David M Holtzman
Journal:  Nat Neurosci       Date:  2011-05-01       Impact factor: 24.884

8.  Assessment of α-synuclein secretion in mouse and human brain parenchyma.

Authors:  Evangelia Emmanouilidou; Dimitris Elenis; Themis Papasilekas; Georgios Stranjalis; Kyriaki Gerozissis; Penelopi C Ioannou; Kostas Vekrellis
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

9.  Analysis of in vivo turnover of tau in a mouse model of tauopathy.

Authors:  Kaoru Yamada; Tirth K Patel; Katja Hochgräfe; Thomas E Mahan; Hong Jiang; Floy R Stewart; Eva-Maria Mandelkow; David M Holtzman
Journal:  Mol Neurodegener       Date:  2015-10-26       Impact factor: 14.195

10.  Neuronal activity regulates extracellular tau in vivo.

Authors:  Kaoru Yamada; Jerrah K Holth; Fan Liao; Floy R Stewart; Thomas E Mahan; Hong Jiang; John R Cirrito; Tirth K Patel; Katja Hochgräfe; Eva-Maria Mandelkow; David M Holtzman
Journal:  J Exp Med       Date:  2014-02-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.